Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Moodys
Johnson and Johnson
Harvard Business School
Julphar
Farmers Insurance
McKesson
Baxter
Medtronic

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020037

« Back to Dashboard

NDA 020037 describes VOLTAREN, which is a drug marketed by Glaxosmithkline Cons and Novartis and is included in four NDAs. It is available from eighteen suppliers. Additional details are available on the VOLTAREN profile page.

The generic ingredient in VOLTAREN is diclofenac sodium. There are forty-seven drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the diclofenac sodium profile page.
Summary for 020037
Tradename:VOLTAREN
Applicant:Novartis
Ingredient:diclofenac sodium
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Dermatological Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020037
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VOLTAREN diclofenac sodium SOLUTION/DROPS;OPHTHALMIC 020037 NDA Novartis Pharmaceutical Corporation 0078-0478 E 0078-0478-61
VOLTAREN diclofenac sodium SOLUTION/DROPS;OPHTHALMIC 020037 NDA Citra Labs 23731-6051 N 23731-6051-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.1%
Approval Date:Mar 28, 1991TE:ATRLD:Yes

Expired US Patents for NDA 020037

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis VOLTAREN diclofenac sodium SOLUTION/DROPS;OPHTHALMIC 020037-001 Mar 28, 1991 ➤ Sign Up ➤ Sign Up
Novartis VOLTAREN diclofenac sodium SOLUTION/DROPS;OPHTHALMIC 020037-001 Mar 28, 1991 ➤ Sign Up ➤ Sign Up
Novartis VOLTAREN diclofenac sodium SOLUTION/DROPS;OPHTHALMIC 020037-001 Mar 28, 1991 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
US Department of Justice
Federal Trade Commission
Citi
Cerilliant
Daiichi Sankyo
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.